157 related articles for article (PubMed ID: 30042699)
1. A Randomized Trial of Personalized Cognitive-Behavior Therapy for Alcohol Use Disorder in a Public Health Clinic.
Coates JM; Gullo MJ; Feeney GFX; Young RM; Connor JP
Front Psychiatry; 2018; 9():297. PubMed ID: 30042699
[No Abstract] [Full Text] [Related]
2. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
Kelly JF; Humphreys K; Ferri M
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Reducing Craving in Alcohol Use Disorder Using a Serious Game (SALIENCE): Randomized Controlled Trial.
Weber A; Shevchenko Y; Gerhardt S; Hoffmann S; Kiefer F; Vollstädt-Klein S
JMIR Form Res; 2023 Nov; 7():e42194. PubMed ID: 37934561
[TBL] [Abstract][Full Text] [Related]
4. A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.
Manning V; Piercy H; Garfield JBB; Clark SG; Andrabi MN; Lubman DI
JMIR Mhealth Uhealth; 2021 Dec; 9(12):e31353. PubMed ID: 34890355
[TBL] [Abstract][Full Text] [Related]
5. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
6. Neural correlates of drinking reduction during cognitive behavioral therapy for alcohol use disorder.
Naqvi NH; Srivastava AB; Sanchez-Peña J; Lee J; Mariani JJ; Patel GH; Levin FR
bioRxiv; 2023 Feb; ():. PubMed ID: 36798260
[TBL] [Abstract][Full Text] [Related]
7. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
[TBL] [Abstract][Full Text] [Related]
8. Alcohol expectancies pre-and post-alcohol use disorder treatment: Clinical implications.
Coates JM; Gullo MJ; Feeney GFX; Young RM; Dingle GA; Connor JP
Addict Behav; 2018 May; 80():142-149. PubMed ID: 29407685
[TBL] [Abstract][Full Text] [Related]
9. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
[TBL] [Abstract][Full Text] [Related]
10. Baclofen for alcohol use disorder.
Minozzi S; Saulle R; Rösner S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
[TBL] [Abstract][Full Text] [Related]
11. Neural correlates of drinking reduction during a clinical trial of cognitive behavioral therapy for alcohol use disorder.
Naqvi NH; Srivastava AB; Sanchez-Peña J; Lee JK; Drysdale AT; Mariani JJ; Ochsner KN; Morgenstern J; Patel GH; Levin FR
Alcohol Clin Exp Res (Hoboken); 2024 Feb; 48(2):260-272. PubMed ID: 38225187
[TBL] [Abstract][Full Text] [Related]
12. Effects of 10 add-on HF-rTMS treatment sessions on alcohol use and craving among detoxified inpatients with alcohol use disorder: a randomized sham-controlled clinical trial.
Hoven M; Schluter RS; Schellekens AF; van Holst RJ; Goudriaan AE
Addiction; 2023 Jan; 118(1):71-85. PubMed ID: 35971295
[TBL] [Abstract][Full Text] [Related]
13. The role of stress-reactivity, stress-recovery and risky decision-making in psychosocial stress-induced alcohol consumption in social drinkers.
Clay JM; Parker MO
Psychopharmacology (Berl); 2018 Nov; 235(11):3243-3257. PubMed ID: 30209533
[TBL] [Abstract][Full Text] [Related]
14. Craving mediates the effect of impulsivity on lapse-risk during alcohol use disorder treatment.
Coates JM; Gullo MJ; Feeney GFX; McD Young R; Dingle GA; Clark PJ; Connor JP
Addict Behav; 2020 Jun; 105():106286. PubMed ID: 32007828
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Treatment Outcome, Follow-Up, and Abstinence Rates Among Patients With Alcohol Use Disorder: A Prospective Study.
Gc M; Sankaran A; Subramanian K; Subramanian E
Cureus; 2022 Nov; 14(11):e31356. PubMed ID: 36514662
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial.
Trojak B; Soudry-Faure A; Abello N; Carpentier M; Jonval L; Allard C; Sabsevari F; Blaise E; Ponavoy E; Bonin B; Meille V; Chauvet-Gelinier JC
Trials; 2016 May; 17(1):250. PubMed ID: 27188795
[TBL] [Abstract][Full Text] [Related]
17. A multi-site randomized study to compare the effects of Eye Movement Desensitization and Reprocessing (EMDR) added to TAU versus TAU to reduce craving and drinking behavior in alcohol dependent outpatients: study protocol.
Markus W; de Weert-van Oene GH; Becker ES; DeJong CA
BMC Psychiatry; 2015 Mar; 15():51. PubMed ID: 25884223
[TBL] [Abstract][Full Text] [Related]
18. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
[TBL] [Abstract][Full Text] [Related]
19. A Randomized Trial of Combined tDCS Over Right Inferior Frontal Cortex and Cognitive Bias Modification: Null Effects on Drinking and Alcohol Approach Bias.
Claus ED; Klimaj SD; Chavez R; Martinez AD; Clark VP
Alcohol Clin Exp Res; 2019 Jul; 43(7):1591-1599. PubMed ID: 31081924
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of non-consumption outcome measures in alcohol use disorder treatment.
Kirouac M; Witkiewitz K
Addiction; 2019 Jun; 114(6):1086-1092. PubMed ID: 30650471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
